PEPTIDE UND BINDUNGSPARTNER DAFÜR

European patent · EP2984103 · In force

Register entry

Publication number
EP2984103
Application number
EP14722312
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 10, 2014
Published
Feb 17, 2016
Granted
Jun 12, 2019
Protection ends at the latest
Apr 9, 2034
Next annual fee due
Apr 30, 2027
IPC classes
C07K 14/40 (2006.01)
Priority
GB 201306588 11.04.2013
PCT application
PCT/GB2014/051118 10.04.2014
PCT publication
WO2014/167335 16.10.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 21, 2026

    Change

    Published in Swissreg on 21.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Oct 5, 2019

    Agent entered

    Representative
    Latscha Schöllhorn Partner AG, Grellingerstrasse 60, 4052 Basel

    Published in Swissreg on 05.10.2019

  6. Jun 12, 2019

    Granted

    Published in Swissreg on 12.06.2019

Parties

Holder

Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. -Hans-Knöll-Institut- (HKI)

Beutenbergstrasse 11a, 07745 Jena, DE

King's College London

London WC2R 2LS, GB

Agent

Latscha Schöllhorn Partner AG

Grellingerstrasse 60, 4052 Basel

Inventor

HOFS, Sarah

07749 Jena, DE

RICHARDSON, Jonathan

London SE1 1UL, GB

NAGLIK, Julian

London SE1 1UL, GB

WILSON, Duncan

Aberdeen AB25 3SD, GB

TANG, Shirley

London SE1 1UL, GB

MOYES, David

London SE1 1UL, GB

HUBE, Bernhard

07743 Jena, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.